Patents by Inventor Sergei O. Bachurin

Sergei O. Bachurin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080234310
    Abstract: The present invention provides a pharmacological agent based on derivatives of hydrogenated pyrido (4,3-b) indoles and uses thereof. Specifically, the invention provides a geroprotector in the series of hydrogenated pyrido (4,3-b) indoles (several derivatives), which can be used for slowing aging, prolonging lifespan of an individual or cells in an individual, and/or improving quality of life of an individual developing or having a risk of developing age-associated manifestations and/or pathologies.
    Type: Application
    Filed: December 8, 2004
    Publication date: September 25, 2008
    Inventors: Sergei O. Bachurin, Vladimir V. Grigoriev
  • Patent number: 7071206
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: July 4, 2006
    Assignee: Medivation, Inc.
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladmir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva
  • Publication number: 20040044022
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided.
    Type: Application
    Filed: August 28, 2003
    Publication date: March 4, 2004
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladimir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva
  • Publication number: 20020115682
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided.
    Type: Application
    Filed: January 23, 2002
    Publication date: August 22, 2002
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladimir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva
  • Patent number: 6353015
    Abstract: This invention relates to the use of N-acetyl-serotonin (NAS) derivatives for the treatment and prophylaxis of neurological injury and neurodegenerative disorders in a mammal.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: March 5, 2002
    Assignee: St. Elizabeth's Medical Center
    Inventors: Gregory F. Oxenkrug, Sergei O. Bachurin, Andrey Zakharovic Afanasiev, Pura J. Requintina
  • Publication number: 20010020028
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided.
    Type: Application
    Filed: February 6, 2001
    Publication date: September 6, 2001
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladimir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva
  • Patent number: 6187785
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py—(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line, i.e. — represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: February 13, 2001
    Assignee: Selena Pharmaceuticals, Inc.
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladimir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva